March 7, 2017 6:00 am
Today, that road is nearly gone. Isle de Jean Charles, located 80 miles from New Orleans, has been sinking slowly. Since 1955, it has lost 98% of its land mass to rising sea levels, devastating hurricanes, and the construction of oil and gas canals along the marsh.
February 6, 2017 9:00 am
Donald Trump will be coming into office waving the banner of deregulation. While most of the speculation about his plans has focused on the financial industry and the possibility of eviscerating Dodd-Frank reforms, keep your eyes on the Food and Drug Administration. In a Trump administration the agency, figuratively speaking, will have a big bull’s-eye on its back.
February 1, 2017 9:00 am
Kaveh Daneshvar was thrilled when he was invited to speak at a molecular biology meeting next month in Banff, Canada. Daneshvar, a molecular geneticist, is finishing a postdoc at Harvard Medical School and Massachusetts General Hospital in Boston and preparing to go on the job market. He hoped that the conference talk would give him much-needed exposure to leaders in his field.
January 5, 2017 9:00 am
House Republicans have reversed themselves and restored the current rules of the Office of Congressional Ethics
December 15, 2016 9:00 am
The data are the first to quantify the risks to women infected at different times during pregnancy, and they seem to confirm that they are highest early in pregnancy.
December 9, 2016 9:00 am
The discovery of the black-hole firewall paradox — one of the most confounding puzzles to emerge in physics in recent years — has bagged its co-founder a share of one of this year’s US$3-million Breakthrough Prizes.
November 24, 2016 9:00 am
A new language of carbon recognizes the material and quality of carbon so that we can imagine and implement new ways forward
November 21, 2016 9:00 am
The new administration will insert a mission to the lunar surface, probably international in character, as a step on the way to Mars
November 1, 2016 12:12 pm
Vindication was three years coming for Ethan Perlstein. On 19 October, his California biotechnology company, Perlara, announced a deal with Novartis. The Swiss drug giant will test a compound that Perlara has identified as a possible treatment for a rare childhood disease, and will invest an undisclosed sum in the smaller firm.
October 26, 2016 8:00 am
Digital gizmos can monitor your heart, whether it’s a wrist-worn fitness tracker or a smartphone app to help cardiologists analyze diagnostic tests. The question is whether they’re going to do your heart any good. The short answer: It depends.